References

REFERENCES

1. Rosenfield A. Abortion and women's reproductive health. Int J Gynaecol Obstet 1994;46:173 - 9.
   
2. Cates W Jr, Grimes DA. Deaths from second trimester abortion by dilation and evacuation: causes, prevention, facilities. Obstet Gynecol 1981;58:401 - 8.
   
3. Grimes DA, Cates W Jr, Selik RM. Abortion facilities and the risk of death. Fam Plann Perspect 1981;13:30 - 2.
   
4. Henshaw SK. Factors hindering access to abortion services. Fam Plann Perspect 1995;27:54 - 9.
   
5. Statistics Canada. Induced (Therapeutic) Abortion 2000. Ottawa: Health Statistics Division; 2000. Available at: www.statcan.ca/. Accessed: July 10, 2006.
   
6. Davis VJ, Mykitiuk R. The rights of the adolescent: the mature minor. J Soc Obstet Gynaecol Can 2001; 23(4):343 - 5.
   
7. Larsson PG, Platz-Christensen JJ, Thejls H, Forsum U, Pahlson C. Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis: a double-blind randomized study. Am J Obstet Gynecol 1992;166:100 - 3.
   
8. Wiebe ER. Abortion induced with methotrexate and misoprostol. Can Med Assoc J 1996;154:165 - 70.
   
9. Cameron ST, Glassier AF, Logan J, Benton L, Baird DT. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh. Br J Obstet Gynaecol 1996;103:1222 - 9.
   
10. Blayo C. L'evolution du recours a l'avortement en France depuis 1976. Population 1995;779 - 810.
    
11. Creinin MD, Darney PD. Methotrexate and misoprostol for early abortion. Contraception 1993;48:339 - 48.
    
12. Creinin MD, Vittinghoff E, Keder L, Darney PD, Tiller G. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy. Contraception 1996;53:321 - 7.
    
13. Creinin MD. Oral methotrexate and vaginal misoprostol for early abortion. Contraception 1996;54:15 - 8.
    
14. Creinin MD, Vittinghoff E, Schaff E, Klaisle C, Darney PD, Dean C. Medical abortion with oral methotrexate and vaginal misoprostol. Obstet Gynecol 1997;90:611 - 6.
    
15. Gonzalez CH, Vargus R, Perez AB, Kim CA, Brunoni D, Marques-Dias MJ. Limb deficiency with or without Mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester. Am J Med Genet 1993;47:59 - 64.
    
16. Pastuszak AL, Schuler L, Speck-Martins, CE Coelho KE, Cordello SM, Vargas F. Use of misoprostol during pregnancy and Mobius sequence in infants. N Engl J Med 1998;338:1881 - 5.
    
17. Kozlowski RD, Steinbrunner JV, MacKenzie AH, Clough JD, Wilke WS, Segal AM. Outcome of first trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 1990;88:589 - 92.
    
18. Carbonell JLL, Varela L, Velazco A, Fernandez C. The use of misoprostol for the termination of early pregnancy. Contraception 1997;55:165 - 8.
    
19. Ngai SW, Tang OS, Chan YM, Ho PC. Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: efficacy and acceptability. Hum Reprod 2000;15:2205 - 8.
    
20. Bugalho A, Faundes A, Jamisse L, Usfa M, Maria E, Bique C. Evaluation of vaginal misoprostol to induce first trimester abortion. Contraception 1996;53:243 - 6.
    
21. Borgatta L, Chen A, Mullaly B, Stubblefield PG. Early medical abortion using misoprostol alone in a low income setting. Obstet Gynecol 2003;101:14S.
    
22. Hausknecht RU. Methotrexate and misoprostol to terminate early pregnancy. N Eng J Med 1995;333:537 - 40.
    
23. Grimes D. Medical abortion in early pregnancy: a review of evidence. Obstet Gynecol 1997;89:790 - 6.
    
24. Schaff EA, Wortman M, Eisinger S, Franks P. Methotrexate and misoprostol when surgical abortion fails. Obstet Gynecol 1996;87:450 - 2.
    
25. Davis VJ. Guidelines for medical termination of pregnancy. J Soc Obstet Gynaecol Can 1999;21(12)1169 - 74.
    
26. Lichtenberg ES, Paul M, Jones H. First trimester surgical abortion practices: a survey of National Abortion Federation members. Contraception 2001;64:345 - 52.
    
27. Creinin MD, Edwards J. Early abortion: surgical and medical options. Curr Probl Obstet Gynecol Fertil 1997;20:1 - 32.
    
28. Hodgson JE. A reassessment of menstrual regulation. Stud Fam Plann 1977;8(10):263 - 7.
    
29. Goldberg AB, Dean G, Kang MS, Youssof S, Darney PD. Manual versus electric vacuum aspiration for early first-trimester abortion: a controlled study of complication rates. Obstet Gynecol 2004;103:101.
    
30. Grimes DA, Schulz KF, Cates W Jr, Tyler W Jr. Local versus general anesthesia: which is safer for performing suction curettage abortions? Am J Obstet Gynecol 1979;135(8):1030 - 5.
    
31. Castadot RG. Pregnancy termination: techniques, risks and complications and their management. Fertil Steril 1986;45(1):5 - 17.
    
32. Hern WM. Laminaria in abortion: use in 1368 patients in first trimester abortion. Rocky MT Med J, 1975;72(9):390 - 5.
    
33. Newton BW. Laminaria osmotic dilator: relic of the past or modern medical device? Am J Obstet Gynecol 1979;113(4):442 - 8.
    
34. El-Refaey H, Calder L, Wheatley, Templeton A. Cervical priming with prostaglandin E1 analogues, misoprostol and gemeprost. Lancet 1994;343:1207 - 9.
    
35. Goldberg AB, Greenberg MB, Darney PD. Drug therapy: misoprostol and pregnancy. N Engl J Med 2001;344:38 - 7.
    
36. Ngai SW, Tang OS, Lao T, Ho PC, Ma HK. Oral misoprostol versus placebo for cervical dilatation prior to vacuum aspiration in first trimester pregnancy. Hum Reprod 1995;10:1220 - 2.
    
37. Schultz KF, Grimes DA, Cates W Jr. Measures to prevent cervical injury during suction curettage abortion. Lancet 1983;1:1182 - 4.
    
38. Grimes DA, Schultz KF, Cates W Jr. Prevention of uterine perforation during curettage abortion. JAMA 1984;251:2108 - 11.
    
39. Durack DT. Prevention of infective endocarditis. N Engl J Med 1995;332:38 - 44.
    
40. Sawaya GF, Grady D, Kerlikowske K, Grimes DA. Antibiotics at the time of induced abortion: the case for universal prophylaxis based on a meta-analysis. Obstet Gynecol 1996;87:884 - 90.
    
41. Jones JL, Kaunitz AM. Medical screening. In: Policar MJ, Pollack AE, eds. Clinical training curriculum in abortion practice. Washington, DC: National Abortion Federation. 1995.
    
42. Grimes DA, Schulz KF, Cates W Jr. Prophylactic antibiotics for curettage abortion. Am J Obstet Gynecol 1984;150:689 - 94.
    
43. Lichtenberg ES, Paul ME, Saporta V. 1997 Provider clinical survey: first trimester surgical abortion practice. Washington, DC: National Abortion Federation; 1997.
    
44. Smith GM, Stubblefield PG, Chirchirillo L, McCarthy MJ. Pain of first trimester abortion: its quantification and relations with other variables. Am J Obstet Gynecol 1979;133:489 - 98.
    
45. Suprapto K, Reed S. Naproxen sodium for pain relief in first-trimester abortion. Am J Obstet Gynecol 1984;150:1000 - 1.
    
46. Keder LM. Best practices in surgical abortion. Am J Obstet Gynecol 2003;189:418 - 22.
    
47. Wong CY, Ng EH, Ngai SW, Ho PC. A randomized, double blind, placebo-controlled study to investigate the use of conscious sedation in conjunction with paracervical block for reducing pain in termination of first trimester pregnancy by suction evacuation. Hum Reprod 2002;17:1222 - 5.
    
48. Rawling MJ, Wiebe ER. A randomized controlled trial of fentanyl for abortion pain. Am J Obstet Gynecol 2001;185:103 - 7.
    
49. Schultz KF, Grimes DA, Christensen DD. Vasopressin reduces blood loss from second-trimester dilatation and evacuation abortion. Lancet 1985;2:353 - 6.
    
50. Penfield AJ. Gynecologic surgery under local anaesthesia. In: Penfield AJ, ed. Gynecologic surgery under local anaesthesia. Baltimore-Munich: Urban and Schwarzenberg;1986:48 - 9.
    
51. Hodgson JE. Abortion by vacuum aspiration. In: Hodgson JE, ed. Abortion and sterilization: medical and social aspects. New York: Grune and Strattion;1981:225.
    
52. Laurensen NH, Conrad P. Effect of oxytocin agents on blood loss during first trimester suction curettage. Obstet Gynecol 1974;44:428 - 33.
    
53. Munsick RA. Clinical test for placenta in 100 consecutive menstrual aspirations. Obstet Gynecol 1982;60:738 - 41.
    
54. Stubblefield PG, Berek JS. Anatomical and clinical correlations of uterine perforations. Am J Obstet Gynecol 1979;135:181 - 4.
    
55. Lindell G. Flam F. Management of uterine perforations in connection to legal abortions. Acta Obstet Gynecol 1995;74:373 - 5.